-
1
The correction updates the Methods description of annual PFB diagnosis prevalence among veterans receiving VHA outpatient care.
-
2
Mean prevalence for fiscal years 2016-2022 was calculated overall, by age, and within sex strata by self-reported race and ethnicity.
-
3
In sensitivity analyses requiring at least 2 PFB encounters separated by 30 days or more, prevalence was 5.6 per 10 000 veterans (95% CI, 5.5-5.7).
-
4
Prevalence estimates are expressed per 10 000 veterans, whereas prevalence ratios are unitless.
-
5
The corrections clarify Table 2 labels and wording; reported values and study conclusions are unchanged.
Based on findings from:
Errors in the Methods, Results, and Table 2
Jama Dermatology, 2026.
https://jamanetwork.com/journals/jamadermatology/fullarticle/2857022
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.